Paasche G: Stenting the Eustachian tube to treat chronic otitis media - a feasibility study in sheep. Head Face Med. 2018; 14(1): 8 Raap M , Gronewold M , Christgen H , Glage S, Bentires-Alj M, Koren S, Derksen

S194; https://doi.org/10.1007/s00347-018-0760-7 Veröffentlichungen 2017 Originalpublikationen Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion

ossler, K., Moorman, A.F., Kispert, A.*, Christoffels, V.M. * (2009). Formation of the Sinus Node Head and Differentiation of Sinus Node Myocardium Are Independently Regulated by Tbx18 and Tbx3. Circ. [...] ssler, K., Moorman, A.F.M., Kispert, A.*, Christoffels, V.M.* (2009). Formation of the Sinus Node Head and Differentiation of Sinus Node Myocardium Are Independently Regulated by Tbx18 and Tbx3. Circ.

us in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO)†. Ann Oncol 2015; 26(3): 561-567 Hardtke-Wolenski

Tiede C, Kreipe H , Hussein K : Expression of Caspase 14 and Filaggrin in Oral Squamous Carcinoma. Head Neck Pathol 2013; 7(4): 327-333 Schober T, Framke T, Kreipe H , Schulz TF, Großhennig A, Hussein K

Hearing4all. The Group The Group Waldo Nogueira Jun. Prof. Dr.-Ing Since 2013 Junior Professor and head of APG 2011-2013 Post-Doc Music Technology Group, University Pompeu Fabra, Barcelona, Spain 2009-2011

(2020). Tolerability of daily intermittent or continuous short-arm centrifugation during 60-day 6o head down bed rest (AGBRESA study). PLoS One. 2020 Sep 18;15(9):e0239228. Frett T, Green DA, Arz M, Noppe

pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma. Ann Oncol 2017; 28(11): 2827-2835 Thomay K, Fedder C, Hofmann W

with MK5 Seminarraum 1330, 12.00 Uhr 13.10.2006 Prof. Theresia Kraft Point mutations in the myosin head domain associated with Familial Hypertrophic Cardiomyopathy Seminarraum 1330, 12.00 Uhr 29.9.2006

us in Platin- and Cetuximab Refractory Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) of the German SCCHN Group (AIO).” Annals of Oncology 26(3):561–67. doi: 10.1093/